Author:
Morais Katia L. P.,Pacheco Mario Thiego Fernandes,Berra Carolina Maria,Bosch Rosemary V.,Sciani Juliana Mozer,Chammas Roger,de Freitas Saito Renata,Iqbal Asif,Chudzinski-Tavassi Ana Marisa
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine
Reference50 articles.
1. Ding F, Xiao H, Wang M, Xie X, Hu F (2014) The role of the ubiquitin-proteasome pathway in cancer development and treatment. Front Biosci (Landmark Ed) 19:886–895
2. Reinstein E, Ciechanover A (2006) Narrative review: protein degradation and human diseases: the ubiquitin connection. Ann Intern Med 145:676–684
3. de Bettignies G, Coux O (2010) Proteasome inhibitors: dozens of molecules and still counting. Biochimie 92:1530–1545. doi: 10.1016/j.biochi.2010.06.023
4. Nawrocki ST, Sweeney-Gotsch B, Takamori R, McConkey DJ (2004) The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts. Mol Cancer Ther 3:59–70
5. Fribley A, Zeng Q, Wang CY (2004) Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. Mol Cell Biol 24:9695–9704. doi: 10.1128/MCB.24.22.9695-9704.2004
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献